Literature DB >> 14973106

Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians.

Susan Nowell1, D Luke Ratnasinghe, Christine B Ambrosone, Suzanne Williams, Terri Teague-Ross, Lyndsey Trimble, Gail Runnels, Alindria Carrol, Bridgett Green, Angie Stone, Don Johnson, Graham Greene, Fred F Kadlubar, Nicholas P Lang.   

Abstract

Exposure to heterocyclic amines may increase prostate cancer risk. Human sulfotransferase 1A1 (SULT1A1) is involved in the bioactivation of some dietary procarcinogens, including the N-hydroxy metabolite of the food-borne heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine. This study compares a polymorphism in the SULT1A1 gene, SULT1A1 enzyme activity, meat consumption, and the risk of prostate cancer in a population based case-control study. Prostate cancer patients (n = 464) and control individuals (n = 459), frequency matched on age and ethnicity, provided informed consent, answered a survey, and provided a blood sample. Platelets were isolated for phenotype analysis, and DNA was isolated from lymphocytes for genotype determination. Meat consumption was assessed using a dietary questionnaire. Caucasians homozygous for the SULT1A1*1 high activity allele were at increased risk for prostate cancer [odds ratio (OR), 1.68; 95% confidence interval (CI), 1.05-2.68] compared with individuals homozygous for the low-activity allele. The association between SULT1A1 genotype and prostate cancer risk in African-Americans did not reach significance (OR, 1.60; 95% CI, 0.46-5.62). When SULT1A1 activity was considered, there was a strong association between increased SULT1A1 activity and prostate cancer risk in Caucasians (OR, 3.04; 95% CI, 1.8-5.1 and OR, 4.96; 95% CI, 3.0-8.3, for the second and third tertiles of SULT1A1 activity, respectively) compared with individuals in the low enzyme activity tertile. A similar association was also found in African-American patients, with ORs of 6.7 and 9.6 for the second and third tertiles of SULT1A1 activity (95% CI, 2.1-21.3 and 2.9-31.3, respectively). When consumption of well-done meat was considered, there was increased risk of prostate cancer (OR, 1.42; 95% CI, 1.01-1.99 and OR, 1.68; 95% CI, 1.20-2.36 for the second and third tertiles, respectively). When SULT1A1 activity was stratified by tertiles of meat consumption, there was greater risk of prostate cancer in the highest tertile of meat consumption. These results indicate that variations in SULT1A1 activity contributes to prostate cancer risk and the magnitude of the association may differ by ethnicity and be modified by meat consumption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973106     DOI: 10.1158/1055-9965.epi-03-0047

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  35 in total

1.  Microarray-based identification of differentially expressed genes in extramammary Paget's disease.

Authors:  Jin-Ran Lin; Jun Liang; Qiao-An Zhang; Qiong Huang; Shang-Shang Wang; Hai-Hong Qin; Lian-Jun Chen; Jin-Hua Xu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

3.  Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Chih-Ming Su; Mei-Chieh Chen; I-Chan Lin; Hsin-An Chen; Ming-Te Huang; Chih-Hsiung Wu; Kun-Hung Shen; Yuan-Hung Wang
Journal:  Tumour Biol       Date:  2014-04-25

4.  Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.

Authors:  Serdal Arslan; Yavuz Silig; Hatice Pinarbasi
Journal:  Exp Ther Med       Date:  2011-08-12       Impact factor: 2.447

5.  A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.

Authors:  Stefania Boccia; Gabriella Cadoni; Giuseppe La Torre; Dario Arzani; Mariangela Volante; Caterina Cattel; Francesco Gianfagna; Gaetano Paludetti; Giovanni Almadori; Gualtiero Ricciardi
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-31       Impact factor: 4.553

6.  The NSAID allosteric site of human cytosolic sulfotransferases.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

7.  Relationship of SULT1A1 copy number variation with estrogen metabolism and human health.

Authors:  Jixia Liu; Ran Zhao; Zhan Ye; Alexander J Frey; Emily R Schriver; Nathaniel W Snyder; Scott J Hebbring
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-01       Impact factor: 4.292

8.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

9.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

10.  Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate.

Authors:  Deliang Tang; Jason J Liu; Cathryn H Bock; Christine Neslund-Dudas; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.